GSK-1070916
CAS: 942918-07-2
Ref. TM-T6129
| 1mg | 48.00 € | ||
| 5mg | 93.00 € | ||
| 10mg | 156.00 € | ||
| 25mg | 259.00 € | ||
| 50mg | 406.00 € | ||
| 100mg | 604.00 € | ||
| 1ml*10 (DMSO) | 104.00 € |
Estimated delivery in United States, on Friday 10 May 2024
Product Information
Name:
GSK-1070916
Synonyms:
- GSK-1070916A, GSK1070916
- 3-(4-(4-(2-(3-((dimethylamino)methyl)phenyl)-1H-pyrrolo[2,3-b]pyridin-4-yl)-1-ethyl-1H-pyrazol-3-yl)phenyl)-1,1-dimethylurea
- Gsk-1070916A
CAS:
Description:
GSK-1070916 (GSK-1070916A) is a reversible and ATP-competitive inhibitor of Aurora B/C with IC50 of 3.5 nM/6.5 nM. It displays >100-fold selectivity against the closely related Aurora A-TPX2 complex. Phase 1.
Brand:
Targetmol
Long term storage:
Notes:
Chemical properties
Molecular weight:
507.63
Formula:
C30H33N7O
Purity:
98.51%
Color/Form:
Solid
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: TM-T6129 GSK-1070916
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
